LATAM News Online
SEE OTHER BRANDS

The latest news from Latin America

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on October 8, 2025

E3 Lithium Announces Upsizing of Previously Announced Equity Offering to $12,180,000
Patria Announces Third Quarter 2025 Investor Call
eToro Group Ltd. to Announce Third Quarter 2025 Results and Hold Investor Webcast on November 10, 2025
Puerto Rico’s Day at The Ballpark Wraps 2025 Season
Critical One Energy Arranges Oversubscribed CDN$7.65 Million Flow-Through Private Placement
XS.com Gana el Premio de “Marca Más Influyente” en el Dubai Forex Expo 2025
XS.com Vence o Prêmio de “Marca Mais Influente” no Dubai Forex Expo 2025
Koryx Files Updated PEA for the Haib Copper Project, Southern Namibia
Chiang Mai Elephant Nature Park Suffers Through Thailand’s Tourism Slowdown
Virginia is the Place to Be! USA and Argentina Rack Up Wins as Games Continue in FIP Arena World Polo Championship
UPDATE - Critical Metals Corp (NASDAQ: CRML) Secures Another Significant Tanbreez Offtake Agreement for 15% of its Production with Leading U.S. Vertically Integrated Rare Earth Company, REalloys Inc.
El icónico Paraíso de la Bonita inaugura la nueva Royalton Reserve Collection
Iconic Paraíso de la Bonita Inaugurates the New Royalton Reserve Collection
dLocal to Report Third Quarter 2025 Financial Results
VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium
Critical Metals Corp (NASDAQ: CRML) Secures Another 10-Year Tanbreez Offtake Agreement for 15% of Production with Leading U.S. Full-Cycle Rare Earth Processor REalloys Inc.
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions